Leadership Overview
Cynosure has 10 executives leading key functions including strategy, finance, technology, operations, legal, and regional management.
Driven by innovation, Cynosure is dedicated to developing and manufacturing energy-based aesthetic and medical treatment systems that enhance offerings and provide the latest treatments to patients worldwide.
Driven by innovation, Cynosure is dedicated to developing and manufacturing energy-based aesthetic and medical treatment systems that enhance offerings and provide the latest treatments to patients worldwide.
Leadership Roles at Cynosure
Gail Fajembola - Managing Director & Chief Executive Officer
Gail Fajembola, the Managing Director & Chief Executive Officer at Cynosure, directs the company's overall strategic vision and operational execution. This leadership role involves guiding the development and manufacturing of energy-based aesthetic and medical treatment systems, ensuring alignment with market demands for hair removal, skin revitalization, and body contouring solutions. Fajembola oversees the integration of innovative technologies and product pipelines, driving the company's expansion into new therapeutic areas and geographic markets. The Chief Executive Officer ensures that all business units operate cohesively to meet global practitioner and physician needs. By fostering a culture of innovation and excellence, Gail Fajembola solidifies Cynosure's position as a leader in the aesthetic and medical treatment sector, impacting the company's financial performance and market share through decisive leadership and strategic planning.
Timothy Gehlmann - Chief Executive Officer & President, Hoya Photonics Inc & of Hoya Photonics Inc
Timothy Gehlmann, the Chief Executive Officer & President, Hoya Photonics Inc & of Hoya Photonics Inc at Cynosure, spearheads the strategic direction and operational oversight for Hoya Photonics Inc. This executive role involves driving innovation in the development and manufacturing of advanced optical and photonic solutions, critical components for Cynosure's energy-based treatment systems. Gehlmann ensures that Hoya Photonics Inc maintains its leadership in producing high-quality components that enhance the efficacy and reliability of Cynosure's diverse product applications, including hair removal and skin revitalization technologies. The Chief Executive Officer & President, Hoya Photonics Inc & of Hoya Photonics Inc oversees research and development initiatives, aiming to integrate cutting-edge photonic advancements into next-generation medical and aesthetic devices. Timothy Gehlmann's leadership focuses on optimizing production processes and supply chain management to meet global demand, directly contributing to Cynosure's overall market competitiveness and technological superiority.
Cyriacus Njoku - Chief Executive Officer & President
Cyriacus Njoku, the Chief Executive Officer & President at Cynosure, commands the overarching strategic initiatives and operational frameworks for the organization. This pivotal role involves steering the company's trajectory in the competitive landscape of energy-based aesthetic and medical treatment systems. Njoku directs the expansion of Cynosure's diverse product portfolio, encompassing applications for hair removal, skin revitalization, scar reduction, and gynecological health. The Chief Executive Officer & President ensures that the company's manufacturing and development processes adhere to the highest standards of innovation and quality, supporting practitioners, physicians, and business owners worldwide. Cyriacus Njoku's leadership focuses on enhancing market penetration and fostering strategic partnerships to solidify Cynosure's global presence and reputation as a premier creator of advanced treatment solutions.
Robert Howe - Chief Financial Officer
Robert Howe, the Chief Financial Officer at Cynosure, directs the company's financial strategy and fiscal operations. This executive function involves overseeing all aspects of financial planning, budgeting, and reporting, ensuring robust fiscal health for the organization. Howe manages investment strategies and capital allocation to support the development and manufacturing of Cynosure's energy-based aesthetic and medical treatment systems, including those for hair removal, skin revitalization, and body contouring. The Chief Financial Officer plays a critical part in evaluating market opportunities and managing financial risks associated with global expansion and product innovation. By ensuring financial discipline and strategic resource deployment, Robert Howe directly contributes to Cynosure's sustained growth and profitability, supporting practitioners and physicians worldwide with reliable and advanced treatment solutions.
Baker Baker - Executive Vice President & Chief Financial Officer
Baker Baker, the Executive Vice President & Chief Financial Officer at Cynosure, collaborates with the Chief Financial Officer to manage the company's financial health and strategic fiscal planning. This executive role involves supporting the oversight of financial reporting, budgeting, and resource allocation for the development and manufacturing of energy-based aesthetic and medical treatment systems. Baker Baker contributes to financial analysis and forecasting, ensuring that Cynosure's investments in areas like hair removal and skin revitalization technologies align with long-term growth objectives. The Executive Vice President & Chief Financial Officer assists in managing financial risks and optimizing capital deployment across global operations. By reinforcing financial controls and supporting strategic financial decisions, Baker Baker ensures the sustained economic viability and market competitiveness of Cynosure's innovative product offerings.
Lowinn Kibbey - President (North America)
Lowinn Kibbey, the President (North America) at Cynosure, directs the company's strategic initiatives and commercial operations across the North American region. This leadership role involves driving market penetration and revenue growth for Cynosure's comprehensive portfolio of energy-based aesthetic and medical treatment systems, including applications for hair removal, skin revitalization, and body contouring. Kibbey oversees sales, marketing, and customer support functions, ensuring alignment with corporate objectives and regional market demands. The President (North America) fosters strong relationships with practitioners, physicians, and business owners, expanding the adoption of Cynosure's innovative technologies. Lowinn Kibbey's focus on regional market dynamics and customer engagement is instrumental in strengthening Cynosure's presence and impact within the vital North American aesthetic and medical treatment sector.
Rafael Sierra - Chief Information Officer & Chief Technology Officer
Rafael Sierra, the Chief Information Officer & Chief Technology Officer at Cynosure, architects the company's technological infrastructure and innovation roadmap. This leadership position involves guiding the development and implementation of advanced information systems and cutting-edge technologies that underpin Cynosure's energy-based aesthetic and medical treatment systems. Sierra oversees the integration of digital solutions that enhance product performance, user experience, and operational efficiency across hair removal, skin revitalization, and body contouring applications. The Chief Information Officer & Chief Technology Officer drives research and development efforts, ensuring Cynosure remains at the forefront of technological advancements in the medical and aesthetic device industry. Rafael Sierra's strategic vision ensures robust data security, scalable IT operations, and the continuous evolution of product technology to meet the dynamic needs of practitioners and physicians globally.
Jae Yoo - Chief Operations Officer
Jae Yoo, the Chief Operations Officer at Cynosure, directs the company's global operational strategies and execution. This leadership role involves optimizing the manufacturing, supply chain, and distribution of Cynosure's diverse range of energy-based aesthetic and medical treatment systems, including those for hair removal, skin revitalization, and body contouring. Yoo ensures efficient production processes and maintains high standards of quality control across all manufacturing facilities. The Chief Operations Officer oversees the seamless integration of operations to support product development and market expansion, ensuring timely delivery of innovative solutions to practitioners and physicians worldwide. Jae Yoo's focus on operational excellence drives efficiency, reduces costs, and enhances the overall reliability of Cynosure's advanced treatment applications, directly impacting customer satisfaction and market leadership.
Sean Flanagan - Chief Legal Officer
Sean Flanagan, the Chief Legal Officer at Cynosure, provides strategic legal counsel and oversees all legal affairs for the organization. This executive function involves managing corporate governance, regulatory compliance, and intellectual property protection for Cynosure's energy-based aesthetic and medical treatment systems. Flanagan ensures that all business practices, product development, and market strategies adhere to international legal standards and industry regulations, particularly concerning devices for hair removal, skin revitalization, and gynecological health. The Chief Legal Officer advises on risk mitigation and manages litigation, safeguarding the company's interests and reputation. Sean Flanagan's expertise is crucial in navigating the complex legal landscape of the medical device industry, supporting Cynosure's global operations and commitment to providing safe and effective treatment solutions.
Bebe Teo - Senior VP (Asia Pacific)
Bebe Teo, the Senior VP (Asia Pacific) at Cynosure, leads the strategic development and commercial execution across the Asia Pacific region. This executive position involves expanding market share and driving sales for Cynosure's advanced energy-based aesthetic and medical treatment systems, covering applications such as hair removal, skin revitalization, and gynecological health. Teo manages regional operations, cultivating key partnerships with practitioners and medical professionals throughout Asia Pacific. The Senior VP (Asia Pacific) ensures that Cynosure's innovative product offerings meet the specific needs and regulatory requirements of diverse markets within the region. Bebe Teo's leadership focuses on enhancing brand presence and customer engagement, solidifying Cynosure's position as a leading provider of cutting-edge treatment solutions across this critical global territory.
Explore Leadership Teams in Manufacturing
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
Company Leadership
DS
Founded in 2009 and headquartered in Somerset, New Jersey, Go!Foton is a company that designs and manufactures probes for optical coherence tomograohy.
Company Leadership SC
GL
EP
NN
PHC Group, founded in 2014, is a global healthcare company that specializes in diagnostic services and healthcare solutions. The company provides a range of medical diagnostic products, technologies, and services to healthcare facilities worldwide. With operations across multiple continents including Asia, Europe, and North America, PHC Group offers innovative healthcare technologies through its mobile applications and digital platforms. The company serves both business and consumer markets with its comprehensive diagnostic tools and medical health solutions.
Company Leadership KD
Founded in 2000 and headquartered in Port Washington, New York, Drive DeVilbiss Healthcare is a company that manufactures a line of durable medical equipment including mobility products, beds, bariatric products, wheelchairs, and more.
Company Leadership DL
EM
RA
Frequently Asked Questions Regarding Cynosure Top Executives and Leadership Team
Unlock more people and company data
